Abcam Plc Stock Price, News & Analysis

ABCM NASDAQ

Company Description

Abcam Plc (NASDAQ: ABCM) is a publicly traded research and development in biotechnology company in the Professional, Scientific, and Technical Services sector.

ABCM stock has declined 100.0% over the past year.

This page provides a comprehensive overview of ABCM stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-100%

Performance 1 year

$0.0

Market Cap

230.2M

Shares outstanding

Abcam Plc (ABCM) stock. Over the past 12 months, the stock has lost 100.0%.

Latest News

View All

December 6, 2023

0.00%

Danaher Completes Acquisition of Abcam

acquisition

December 4, 2023

+0.04%

Acquisition of Abcam by Danaher Approved by the High Court of Justice of England and Wales

November 17, 2023

+3.73%

Abcam Acquisition by Danaher Has Received All Identified Clearances; Transaction Expected to Close on December 6, 2023

acquisition

November 6, 2023

-0.34%

Shareholders of Abcam Approve Proposed Acquisition by Danaher

acquisition

October 17, 2023

-0.39%

Leading Proxy Advisor, ISS, Recommends Shareholders Vote “FOR” Danaher Corporation’s Proposed Acquisition of Abcam

acquisition

October 12, 2023

-0.88%

Independent Directors of Abcam Highlight Compelling Reasons for Shareholders to Support Proposed Sale to Danaher

Abcam Plc has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 6 with negative movement. Key topics include acquisition. View all ABCM news →

SEC Filings

View All

No SEC filings available for ABCM.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

ABCM Company Profile & Sector Positioning

Abcam Plc (ABCM) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NASDAQ.